INCY:NASDAQ
Incyte Corp
$126.93
arrow_upward
+1.83%(+2.28) 1D
$127.29
arrow_upward
+0.28% (+0.36)bedtimeAfter hours
Closed: Sep 22, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$124.72
High
$127.75
Low
$124.01
Mkt. cap
25.73B
Avg. vol.
1.35M
Volume
0.00
P/E ratio
16.17
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$124.72
High
$127.75
Low
$124.01
Mkt. cap
25.73B
Avg. vol.
1.35M
Volume
0.00
P/E ratio
16.17
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Barchart.com
·
4 hours ago
How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
AD HOC NEWS
·
8 hours ago
Incyte stock heads into the open after a 0.5 percent drop
News Corp
·
12 hours ago
Incyte Corp. stock underperforms Tuesday when compared to competitors despite daily gains
Investing.com
·
20 hours ago
Incyte to present inflammation and autoimmunity data at EADV
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com